Survey reflects shift towards more varied data sources

As many as 97% of life science companies expect to use more clinical data from a wider variety of sources over the next three years to make faster, more accurate decisions during trials, according to new research from Tufts Center for the Study of Drug Development.

This is one of the findings of the 2017 eClinical Landscape Study, one of the largest, most in-depth surveys of clinical data management professionals, which found that companies use an average of four data sources in clinical trials today.

In three years, the number of data sources utilized is projected to increase to six, with 70% of companies planning to use a new data source that they are not leveraging today.